Oric Pharmaceuticals, Inc. (ORIC) › Operating Cash FlowOric Pharmaceuticals, Inc. (ORIC) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$20.68M2019: -$23.53M2020: -$45.27M2021: -$59.54M2022: -$75.14M2023: -$85.69M2024: -$112.66M2025: -$110.97M-$110.97M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$110.97M+1.5%2024-$112.66M-31.5%2023-$85.69M-14.0%2022-$75.14M-26.2%2021-$59.54M-31.5%2020-$45.27M-92.4%2019-$23.53M-13.8%2018-$20.68M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share